Related Experiment Video
Updated: Aug 5, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Public Support for State Laws Requiring Addiction Programs to Offer FDA-Approved Medications for Opioid Use Disorder
Colleen L Barry1,2, Sarah Gutkind2, Jeff Niederdeppe1,3
1Cornell Jeb E. Brooks School of Public Policy, Cornell University, Ithaca, NY.
Objective:
The study reported here aimed to examine public attitudes regarding state licensure laws requiring addiction treatment programs to offer Food and Drug Administration-approved medications for opioid use disorder.
Methods:
A national survey with a probability-based national sample of 1,552 adults was fielded April 7-28, 2025, by using a probability-based web panel designed to be representative of the U.S. population.
Results:
Seventy-four percent of respondents supported licensure laws requiring addiction treatment programs to offer medications for opioid use disorder. No differences were detected by race or personal experience with addiction or overdose. Although political conservatives were less likely than moderates or liberals to support licensure laws, support was >66% across the ideological spectrum. Support was high even among respondents reporting high social stigma toward or discriminatory beliefs about people with opioid addiction.
Conclusions:
Robust public support suggests that licensure policies supporting addiction treatment programs could be a promising approach for states to reduce overdose deaths.
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drug Regulation
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Classes and Categories
